Entering text into the input field will update the search result below

Array Biopharma, Inc. (ARRY) CEO Ron Squarer on Q2 2019 Results - Earnings Call Transcript

Feb. 05, 2019 1:34 PM ETArray BioPharma Inc. (ARRY-OLD)1 Comment
SA Transcripts profile picture
SA Transcripts

Array Biopharma, Inc. (NASDAQ:ARRY-OLD) Q2 2019 Earnings Conference Call February 5, 2019 9:00 AM ET

Company Participants

Andrea Flynn - Senior Director, IR & Corporate Communications

Ron Squarer - CEO & Director

Andrew Robbins - COO

Jason Haddock - CFO

Conference Call Participants

Chris Shibutani - Cowen and Company

Anupam Rama - JPMorgan Chase & Co.

Stephen Willey - Stifel, Nicolaus & Company

Michael Schmidt - Guggenheim Securities

James Birchenough - Wells Fargo Securities

Eun Yang - Jefferies

Thomas Smith - SVB Leerink

Varun Kumar - Cantor Fitzgerald & Co.

Paul Choi - Goldman Sachs Group


Good day, ladies and gentlemen, and welcome to the Quarter 2 2019 Array BioPharma Inc. Earnings Conference Call. [Operator Instructions]. As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference, Andrea Flynn. Please go ahead.

Andrea Flynn

Good morning. This is Andrea Flynn. Welcome to Array BioPharma's conference call to discuss our financial results for the second quarter of fiscal 2019. You can join this conference call on Array's website at arraybiopharma.com. We are using slides to accompany our remarks today, which can be downloaded from the Investor Relations section of our website. A replay of the conference call will also be available on our website following today's presentation.

I'd like to introduce Array's Chief Executive Officer, Ron Squarer; our Chief Operating Officer, Andy Robbins; and our Chief Financial Officer, Jason Haddock, who will provide remarks today. Dr. Victor Sandor, our Chief Medical Officer, will be available to answer questions as needed. Before I turn the call over to Ron, I'll remind you of the following safe harbor statement. The matters we are discussing today include projections or other forward-looking statements about the future results, research and development goals of Array and its collaborators, and future financial performance of Array. These statements are estimates based on management's current expectations and

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.